Por: Politico Politics January 01, 2023
The Supreme Court’s decision to temporarily block the Biden White House from terminating a Trump-era policy at the southern border has left administration officials at a crossroads. Having pushed to end Title 42 orders, administration officials are now weighing plans to double down on that authority in order to expand border expulsions with respect to three nationalities. The administration is looking to institute a new humanitarian parole... + full article
CNBC USA Health December 31, 2022
Gilnature Istock Getty ImagesThe Covid omicron XBB.1.5 variant is rapidly becoming dominant in the U.S. because it is highly immune evasive and appears more effective at binding to cells than related subvariants, scientists say.XBB.1.5 now represents about 41% of new cases... + más
Highly Immune Evasive Omicron XBB.1.5 Variant Is Quickly Becoming Dominant in U.S. as It Doubles Weekly | NBC 6 South Florida
What we know about the new COVID-19 variant XBB | The Boston Globe
NBC 6 South Florida USA World December 31, 2022
Gilnature Istock Getty Images Highly Immune Evasive Omicron XBB.1.5 Variant Is Quickly Becoming Dominant in U.S. as It Doubles Weekly data-ellipsis=false> The Covid omicron XBB.1.5 variant is rapidly becoming dominant in the U.S. because it is highly immune evasive and appears... + más
Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles weekly | CNBC
The Boston Globe USA Nation December 29, 2022
A new coronavirus variant dubbed XBB has swiftly spreading in the Northeast, jumping from about 35 percent of cases during the week ending Dec. 17 to just over half of cases last week, according to .Here’s a quick primer on what we know about the variant.It is more... + más
Los Angeles Times USA Science December 07, 2022
The coronavirus has been a shifty foe, with new variants and subvariants rapidly evolving to evade vaccines and treatments. Researchers at Boston’s Dana-Farber Cancer Institute are working on an experimental drug that takes one of the virus’ most dangerous traits — its... + más
ALS drug wins FDA approval despite questionable data | Portland Press Herald
Asi Wind Is a Master Magician. Go Join His ‘Inner Circle’ | The Daily Beast
Ars Technica USA Science November 19, 2022
2 emissions.,image url:https://cdn.arstechnica.net/wp-content/uploads/2022/11/cement-mixer-150x150.jpg,listing image url:https://cdn.arstechnica.net/wp-content/uploads/2022/11/cement-mixer-360x200.jpg}'> Navigate Filter by topic Settings Front page layout Site theme - Nov... + más
Soil’s Power as a Climate Solution Has Often Been Overlooked. Until Now | Time
Here’s How The Ocean is Being Harnessed as a Climate Solution | Time
Forbes USA Tech November 09, 2022
Alex Zhavoronkov, co-founder and CEO of Insilico MedicineAlex Zhavoronkov Within the longevity research community, Alex Zhavoronkov is well-known for his relentless focus. He works seven days a week and takes no holidays. The hard work is paying off: In February, Insilico... + más
FDA approves controversial new drug designed to slow the progression of ALS | CNBC
FDA panel recommends revoking the approval of controversial drug intended to prevent premature birth | CNBC
Forbes USA Business October 28, 2022
Amy Yoder is president and CEO of and an avid promoter of women in agriculture. getty Women have made great strides in business, politics, technology and science. Still, I’ve found that the made by Sigmund Freud back in 1925 that “women oppose change, receive passively, and... + más
Why Leadership Fails. Except When There’s Context & Truth-To-Power Teams. | Forbes
About iurex | Privacy Policy | Disclaimer |